BMJ Open · 2018 · 14 citations · 33 references
MedicineSurgeryAntimicrobial PharmacotherapyInfection PreventionPerioperative Infection PreventionAntibiotic ProphylaxisAntimicrobial ProphylaxisHealthcare-associated Infection PreventionPostoperative Infection PreventionProphylactic Antimicrobial UseSurgical Site InfectionAntibiotic Prophylaxis AdministrationInfection Prevention After SurgeryLaparoscopic Colorectal SurgeryPerioperative Antimicrobial ProphylaxisSurgical Site Infection ProphylaxisSurgical Site Infection ReductionSystemic Antibiotic ProphylaxisSystemic Antimicrobial Therapy
INTRODUCTION: Surgical site infections (SSIs) account for 30% of all healthcare-associated infections, with reported rates ranging from 8% and 30% after colorectal surgery and are associated with increased morbidity and mortality rates, length of hospital stay and costs in healthcare. Administration of systemic antimicrobial prophylaxis before surgery is recommended to reduce the risk of SSI, but the optimal regimen remains unclear. We aim to evaluate whether a combined oral and intravenous antimicrobial prophylaxis could be more effective to reduce the incidence of SSI after colorectal surgery, as compared with the standard practice of intravenous antimicrobial prophylaxis alone. METHODS AND ANALYSIS: Comparison of intravenous versus combined oral and intravenous antimicrobial prophylaxis (COMBINE) trial is a randomised, placebo-controlled, parallel, double-blind, multicentre study of 960 patients undergoing elective colorectal surgery. Patients will be randomly allocated in a 1:1 ratio to receive either combined oral and intravenous antimicrobial prophylaxis or intravenous antibiotic prophylaxis alone, stratified by centre, the surgical procedure (laparoscopic or open surgery) and according to the surgical skin antisepsis (chlorexidine-alcohol or povidione-iodine alcoholic solution). The primary endpoint is the rate of SSI by day 30 following surgery, with SSI defined by the criteria developed by the Centers for Disease Control and Prevention. Data will be analysed on the intention-to-treat principle and a per-protocol basis. ETHICS AND DISSEMINATION: COMBINE trial has been approved by an independent ethics committee for all study centres. Participant recruitment began in May 2016. Results will be published in international peer-reviewed medical journals. TRIAL REGISTRATION NUMBER: EudraCT 2015-002559-84; NCT02618720.
33
Classification of Surgical Complications
Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien · Annals of Surgery · 2004 · 30.9K citations · Full text
Medicine, Surgery, General Surgery +13
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
Arif Khwaja · Nephron Clinical Practice · 2012 · 8K citations
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
A.-W. Chan, Jennifer Tetzlaff, Peter C Gøtzsche et al. · BMJ · 2013 · 7.1K citations · Full text